MedKoo Cat#: 412991 | Name: Ipexidine (free base)

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ipexidine (free base) is a biologically active carbamimidoylurea derivative.

Chemical Structure

 Ipexidine (free base)
Ipexidine (free base)
CAS#69017-89-6 (free base)

Theoretical Analysis

MedKoo Cat#: 412991

Name: Ipexidine (free base)

CAS#: 69017-89-6 (free base)

Chemical Formula: C26H54N10O2

Exact Mass: 538.4431

Molecular Weight: 538.79

Elemental Analysis: C, 57.96; H, 10.10; N, 26.00; O, 5.94

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Ipexidine (free base); CK569A; CK-569A; CK 569A
IUPAC/Chemical Name
Ipexidine
InChi Key
OKWNVUAQDQVEOQ-UHFFFAOYSA-N
InChi Code
InChI=1S/C26H54N10O2/c1-3-5-7-9-13-31-25(37)33-23(27)29-15-11-17-35-19-21-36(22-20-35)18-12-16-30-24(28)34-26(38)32-14-10-8-6-4-2/h3-22H2,1-2H3,(H4,27,29,31,33,37)(H4,28,30,32,34,38)
SMILES Code
CCCCCCNC(NC(NCCCN1CCN(CC1)CCCNC(NC(NCCCCCC)=O)=N)=N)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 538.79 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Melsen B, Agerbaek N, Zeuner E, Rölla G. Plaque inhibition by guanidino propyl piperazine (CKO 569A). Scand J Dent Res. 1980 Jun;88(3):210-3. doi: 10.1111/j.1600-0722.1980.tb01216.x. PMID: 6997979. 2: Wennström JL. Effect of a new anti-plaque agent (CK-0569A) on developing plaque and gingivitis in man. J Periodontol. 1982 Mar;53(3):188-94. doi: 10.1902/jop.1982.53.3.188. PMID: 6951032. 3: Shern RJ, Monell-Torrens E, Kingman A. Effect of two recently developed antiseptics on dental plaque and caries in rats. Caries Res. 1985;19(5):458-65. doi: 10.1159/000260882. PMID: 3864547. 4: Yankell SL, Moreno OM, Saffir AJ, Lowary RL, Gold W. Effects of chlorhexidine and four antimicrobial compounds on plaque, gingivitis, and staining in beagle dogs. J Dent Res. 1982 Sep;61(9):1089-93. doi: 10.1177/00220345820610091201. PMID: 6763045. 5: Hurttia H, Knuuttila M, Söderling E, Luostarinen V, Paunio K. Vascular and cellular responses to guanidino propyl piperazine CK0569A, a new anti-plaque agent. Scand J Dent Res. 1987 Apr;95(2):104-11. doi: 10.1111/j.1600-0722.1987.tb01815.x. PMID: 3470903.